Literature DB >> 31971877

Blue Dye Embolization of Renal Tumor: A New Technique to Improve Tumor Localization During Laparoscopic Partial Nephrectomy.

Antoine Bouvier1, Louis Besnier1, A Paisant1, Thomas Briot2, Thomas Hebert3, Valérie Daniel2, Laurent Beydon4, Merzouka Zidane Marinnes5, Nathalie Baize6, Christophe Aubé1, Pierre Bigot7.   

Abstract

Purpose: To improve the tumor localization during laparoscopic surgery, we describe an innovative technique involving superselective intra-arterial injection of blue dye in tumoral vessels to color the tumor before surgical enucleation. Materials and
Methods: The dye injection was performed at the same time as superselective embolization, immediately before laparoscopic surgery in a hybrid operating room. We used this new treatment sequence on 50 consecutive patients.
Results: The selective intra-arterial injection of an emulsion of blue dye and lipiodol was feasible in 46 (92%) cases and well tolerated, followed by superselective embolization of the tumor vessels with glue or coils. The tumor was easily localized during surgery due to the blue coloration. Tumor coloration was not associated with postoperative complication, especially allergic reaction or renal failure. Pathologic analysis of the tumor was not modified by the coloration and all tumors had negative surgical margins. Conclusions: The preoperative dye localization is a feasible, safe, and accurate procedure. This combined approach reduces the difficulty of surgery and increases patient safety.

Entities:  

Keywords:  Patent Blue V; nephron sparing surgery; renal cell carcinoma; selective embolization

Year:  2020        PMID: 31971877     DOI: 10.1089/lap.2019.0686

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  1 in total

1.  Renal function after partial nephrectomy following intra-arterial embolization of renal tumors.

Authors:  Germain Bréhier; Antoine Bouvier; Louis Besnier; Serge Willoteaux; Cosmina Nedelcu; Thibaut Culty; Christophe Aubé; Pierre Bigot
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.